Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of β cells derived from ductal cells

Takeki Ogata, Kee Young Park, Masaharu Seno, Itaru Kojima

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The present study was conducted in an attempt to treat streptozotocin (STZ)-induced hyperglycemia by transplanting β cells derived from pancreatic ductal cells. Ductal cells obtained from neonatal rats were cultured in vitro. Approximately 70% of the cells were converted to insulin-secreting cells by incubating with betacellulin and activin A. Differentiated cells responded to a depolarizing concentration of potassium, tolbutamide and a high concentration of glucose, and insulin secretion increased by 2.5-, 2.3- and 1.6-fold, respectively. We then prepared pseudoislets using the differentiated cells, which exhibited greatly improved glucose-responsiveness, with a high concentration of glucose inducing a 3-fold increase in insulin secretion. We transplanted these pseudoislets into the portal vein of STZ-treated nude mice. Before transplantation, the plasma glucose concentration was above 400 mg/dl, and after transplantation it was markedly reduced, the effect of which persisted for two weeks. These results indicate that STZ-induced hyperglycemia can be treated by transplanting pseudoislets consisting of β cells derived from ductal cells.

Original languageEnglish
Pages (from-to)381-386
Number of pages6
JournalEndocrine Journal
Volume51
Issue number3
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Streptozocin
Hyperglycemia
Transplantation
Glucose
Insulin
Tolbutamide
Insulin-Secreting Cells
Portal Vein
Nude Mice
Potassium

Keywords

  • β Cell
  • Ductal cell
  • Insulin
  • Presudoislet
  • Transplantation

ASJC Scopus subject areas

  • Endocrinology

Cite this

Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of β cells derived from ductal cells. / Ogata, Takeki; Park, Kee Young; Seno, Masaharu; Kojima, Itaru.

In: Endocrine Journal, Vol. 51, No. 3, 06.2004, p. 381-386.

Research output: Contribution to journalArticle

@article{b1f522843ca144b29339e8289156a3df,
title = "Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of β cells derived from ductal cells",
abstract = "The present study was conducted in an attempt to treat streptozotocin (STZ)-induced hyperglycemia by transplanting β cells derived from pancreatic ductal cells. Ductal cells obtained from neonatal rats were cultured in vitro. Approximately 70{\%} of the cells were converted to insulin-secreting cells by incubating with betacellulin and activin A. Differentiated cells responded to a depolarizing concentration of potassium, tolbutamide and a high concentration of glucose, and insulin secretion increased by 2.5-, 2.3- and 1.6-fold, respectively. We then prepared pseudoislets using the differentiated cells, which exhibited greatly improved glucose-responsiveness, with a high concentration of glucose inducing a 3-fold increase in insulin secretion. We transplanted these pseudoislets into the portal vein of STZ-treated nude mice. Before transplantation, the plasma glucose concentration was above 400 mg/dl, and after transplantation it was markedly reduced, the effect of which persisted for two weeks. These results indicate that STZ-induced hyperglycemia can be treated by transplanting pseudoislets consisting of β cells derived from ductal cells.",
keywords = "β Cell, Ductal cell, Insulin, Presudoislet, Transplantation",
author = "Takeki Ogata and Park, {Kee Young} and Masaharu Seno and Itaru Kojima",
year = "2004",
month = "6",
doi = "10.1507/endocrj.51.381",
language = "English",
volume = "51",
pages = "381--386",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of β cells derived from ductal cells

AU - Ogata, Takeki

AU - Park, Kee Young

AU - Seno, Masaharu

AU - Kojima, Itaru

PY - 2004/6

Y1 - 2004/6

N2 - The present study was conducted in an attempt to treat streptozotocin (STZ)-induced hyperglycemia by transplanting β cells derived from pancreatic ductal cells. Ductal cells obtained from neonatal rats were cultured in vitro. Approximately 70% of the cells were converted to insulin-secreting cells by incubating with betacellulin and activin A. Differentiated cells responded to a depolarizing concentration of potassium, tolbutamide and a high concentration of glucose, and insulin secretion increased by 2.5-, 2.3- and 1.6-fold, respectively. We then prepared pseudoislets using the differentiated cells, which exhibited greatly improved glucose-responsiveness, with a high concentration of glucose inducing a 3-fold increase in insulin secretion. We transplanted these pseudoislets into the portal vein of STZ-treated nude mice. Before transplantation, the plasma glucose concentration was above 400 mg/dl, and after transplantation it was markedly reduced, the effect of which persisted for two weeks. These results indicate that STZ-induced hyperglycemia can be treated by transplanting pseudoislets consisting of β cells derived from ductal cells.

AB - The present study was conducted in an attempt to treat streptozotocin (STZ)-induced hyperglycemia by transplanting β cells derived from pancreatic ductal cells. Ductal cells obtained from neonatal rats were cultured in vitro. Approximately 70% of the cells were converted to insulin-secreting cells by incubating with betacellulin and activin A. Differentiated cells responded to a depolarizing concentration of potassium, tolbutamide and a high concentration of glucose, and insulin secretion increased by 2.5-, 2.3- and 1.6-fold, respectively. We then prepared pseudoislets using the differentiated cells, which exhibited greatly improved glucose-responsiveness, with a high concentration of glucose inducing a 3-fold increase in insulin secretion. We transplanted these pseudoislets into the portal vein of STZ-treated nude mice. Before transplantation, the plasma glucose concentration was above 400 mg/dl, and after transplantation it was markedly reduced, the effect of which persisted for two weeks. These results indicate that STZ-induced hyperglycemia can be treated by transplanting pseudoislets consisting of β cells derived from ductal cells.

KW - β Cell

KW - Ductal cell

KW - Insulin

KW - Presudoislet

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=3242759174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242759174&partnerID=8YFLogxK

U2 - 10.1507/endocrj.51.381

DO - 10.1507/endocrj.51.381

M3 - Article

C2 - 15256786

AN - SCOPUS:3242759174

VL - 51

SP - 381

EP - 386

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 3

ER -